Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

Delayed Quote. Delayed  - 05/24 03:36:25 pm
250.2 CHF   +0.93%
03:16p CHUGAI PHARMACE : Anti-Cancer Agent 'Avastin,' Obtained Approval for..
02:59p ROCHE : Lariam only to be considered as a last resort, says Defence ..
01:26p ROCHE : Lariam should be 'drug of last resort' for troops
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ROCHE HOLDING LTD.
03:16p CHUGAI PHARMACEUTICAL : Anti-Cancer Agent 'Avastin,' Obtained Approval for Addit..
02:59p ROCHE : Lariam only to be considered as a last resort, says Defence Committee
01:26p ROCHE : Lariam should be 'drug of last resort' for troops
09:43a ROCHE : MPs say malaria drug Lariam should only be used by UK troops as 'last re..
01:15a ROCHE : MPs sound alarm over British troops' use of malaria drug Lariam
05/23 ROCHE : GSK Price to Drop 67% in China
05/23 ROCHE : Charles Aznavour is 92
05/20 CHUGAI PHARMACEUTICAL : to Present Japanese Phase III Results on Alecensa at ASC..
05/20DJChina Drug Deal Will Slash Prices of Top-Selling Treatments by Up to 67%
05/20 ROCHE : Study reveals Alecensa is effective against specific type of lung cancer..
05/20 CHUGAI PHARMACEUTICAL : and IFReC provide top level Japanese collaboration to be..
05/20 ROCHE : Diagnostics Operations Assigned Patent
05/20 ROCHE : MEDICINE Breast cancer drug is rejected by NICE
05/20 CHUGAI PHARMACEUTICAL : to Present Japanese Phase III Results on Alecensa at ASC..
05/20 Prognosis good for Swiss biotech giant
05/19 CHUGAI PHARMACEUTICAL : Comprehensive Collaboration Agreement between Osaka Univ..
05/19 ROCHE : FDA approves Genentech's Atezolizumab for advanced urothelial carcinoma
05/18DJFDA Approves Roche Immunotherapy for Bladder Cancer--Update
05/18 ROCHE : Phase III Study of Genentech’s Alecensa® (Alectinib) Showed Superi..
05/18 BRISTOL MYERS SQUIBB : FDA OKs immunotherapy drugs for bladder, blood cancers
05/18DJFDA Approves Roche Immunotherapy for Bladder Cancer
05/18 ROCHE : FDA Grants Genentech’s Cancer Immunotherapy TECENTRIQ™ (atez..
05/18 THE INTERVIEW ISSUE : John Lechleiter
05/18 ROCHE : Ex-Marcadia execs raise $1.7M to launch drug firm
05/18 FOUNDATION MEDICINE : Announces Presentations at ASCO
05/17 FOUNDATION MEDICINE : Receives Patent Covering Fundamental Methods in Comprehens..
05/17 CHUGAI PHARMACEUTICAL : Donation to 'Peking University Chugai Medical Foundation..
05/17 CHUGAI PHARMACEUTICAL : Efficacy of 'Actemra Subcutaneous Injection' Confirmed i..
05/17 ROCHE : MOH signs MOU on breast cancer and hepatitis
05/17 FOUNDATION MEDICINE : Receives Patent Covering Fundamental Methods in Comprehens..
05/17 ROCHE : Drags dcgi, hetero to court over copies of its drug
05/16 ROCHE : campaign raises breast cancer awareness
05/16 CHUGAI PHARMACEUTICAL : Immunosuppressant 'CellCept' Obtained Approval for Addit..
05/16 CHUGAI PHARMACEUTICAL : 'Team Chugai' to Take Part in 'Relay for Life Japan' Usi..
05/15 BRIEF : Behrend loses as La Roche forces decisive game for AMCC baseball champio..
05/14 ROCHE : Finland's Faron Pharmaceuticals appoints new medical director
05/13 Announcement of a Lawsuit Filed against Chugai
05/13 CHUGAI PHARMACEUTICAL : - Determination of Terms and Conditions of Stock Options..
05/13 ROCHE : $5,000 Federal Contract Awarded to Roche Diagnostics
05/12 CHUGAI PHARMACEUTICAL : New Cancer Research Findings from Chugai Pharmaceutical ..
05/12 CHUGAI PHARMACEUTICAL : Findings on Thrombosis Reported by Researchers at Chugai..
05/12 Foundation Medicine and AstraZeneca Collaborate to Develop Companion Diagnost..
05/12 FOUNDATION MEDICINE : Announces Commercial Launch of Liquid Biopsy Assay, Founda..
05/11 ROCHE : DiCE Molecules Appoints Industry Veteran Richard Scheller to Board of Di..
05/10 ROCHE : Blueprint Medicines Reports First Quarter 2016 Financial Results
05/10 ROCHE : Xenon Pharmaceuticals Reports First Quarter 2016 Financial Results and P..
05/10 5 Biggest Pharmaceutical Companies by Market Cap
05/10 ROCHE : Bros. to reboot e-commerce
05/09 ROCHE : Curis Reports First Quarter 2016 Financial Results
05/07 DX DIGEST : Foundation Medicine expands companion Dx deal with AstraZeneca; Seeg..
05/07 Foundation Medicine Partners With AstraZeneca, Launches Liquid Biopsy Test, A..
05/06 ROCHE : Announces Direct Sales of Kapa Biosystems NGS Products in Canada
05/06 Cell Source Improving Immunotherapy with T-Cell Twist
05/06 ROCHE : MILITARY $70,627 Federal Contract Awarded to Roche Diagnostics
05/06 ROCHE : Announces Direct Sales of Kapa Biosystems NGS Products in Canada
05/05 ARRAY BIOPHARMA : Genentech Assigned Patent
05/05 ROCHE : Nutley commission candidates address forum
05/05 ROCHE : Corvus Pharmaceuticals Announces First Quarter 2016 Financial Results
05/04 FOUNDATION MEDICINE : Announces Commercial Launch of Liquid Biopsy Assay, Founda..
05/04 Sanofi sees 'strong strategic' fit with U.S. Medivation
05/03 FOUNDATION MEDICINE : reports 1Q loss
05/03 FOUNDATION MEDICINE, INC. : Results of Operations and Financial Condition, Finan..
05/03 ROCHE : FDA Greenlights Zika Blood Center Testing
05/03 ROCHE : Grapevine
05/03 ROCHE : highlights personalised medicines and cancer immunotherapies at 2016 Ame..
05/03 GENENTECH : Highlights Personalized Medicines and Cancer Immunotherapies at 2016..
05/03 FOUNDATION MEDICINE : Announces 2016 First Quarter Results and Recent Highlights
05/03 ROCHE : highlights personalised medicines and cancer immunotherapies at 2016 Ame..
05/02 ROCHE : CHMP recommends EU approval of Roche's Gazyvaro for people with previous..
05/02 ROCHE : Glycotope names new chief medical officer
04/29 FOUNDATION MEDICINE : Horizon Blue Cross Blue Shield of New Jerseys Chief Medica..
04/29 ROCHE : CHMP recommends EU approval of Roche’s Gazyvaro for people with pr..
04/29 ROCHE : CHMP recommends EU approval for Roche's Avastin in combination with Tarc..
04/29 ROCHE : Diagnostics Operations Assigned Patent
04/29DJAstraZeneca's Investment Eats Into Profit
1  2  3  4  5  6  7  8  9  10Next
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials